MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Advancing Global Training and Capacity Building in Parkinson’s Genetics through GP2

    MT. Periñan, S. Dey, S. Finch, H. Leonard, M. Makarious, K. Atterling Brolin, A. Zirra, K. Step, V. van Midden, YW. Tay, Y. Mecheri, L. Faria-Costa, E. Fernandez-Toledo, V. Flores-Ocampo, C. Shambetova, A. Noyce, S. Bandres-Ciga, GP2. Genetics Program (Sevilla, Spain)

    Objective: To promote and facilitate learning by providing resources and expertise to address the training needs of the Global Parkinson’s Genetics Program (GP2; www.gp2.org) and…
  • 2025 International Congress

    Rare Variants, Copy Number Variations, and Heritability Estimates in a Pilot Cohort of Egyptians with Parkinson’s Disease

    M. Yousef, A. El-Hosseiny, A. Nagano, A. Atputhavadivel, E. Khedr, M. William, A. Shalash, G. Fawy, S. El-Shafie, S. El-Jaafary, M. Koraym, Y. Salah, S. Elfarrash, Y. Elsaid, A. Gabr, N. Shebl, L. Aly, N. Abdelwahhab, T. Belal, N. Elsayed, M. El-Gamal, S. Elgamal, S. Ragab, J. Mekky, M. Salama, M. Rizig (Cairo, Egypt)

    Objective: To explore the genetic architecture of Parkinson's disease (PD) in Egypt, addressing the underrepresentation of this population in PD genetics research. Background: Genetic studies…
  • 2025 International Congress

    Predictors of Cognitive Impairments and Mood Disorders after Subthalamic Deep Brain Stimulation in Patients with Parkinson’s Disease

    O. Alenikova, M. Dymkovskaya, A. Bunyak, E. Mykitchuk, S. Kantsevich (Minsk, Belarus)

    Objective: We aimed to determine the predictors of cognitive decline and mood disorders after STN-DBS in PD. Background: Cognitive impairment and mood disorders are the…
  • 2025 International Congress

    Deep Brain Stimulation (DBS) Placement in a Patient with Parkinson’s disease (PD) and Polyostotic Fibrous Dysplasia (PFD)

    D. Kaul, P. Pezeshkian, E. Call, S. Nandipati, D. Bruce, M. Cochran Abraham, S. Khandhar (Walnut Creek, USA)

    Objective: To describe a patient who has PD and a history of PFD implanted with DBS. Background: PD is the second most common neurogenerative disorder…
  • 2025 International Congress

    Minimally Invasive Magnetic Resonance Imaging guided Deep Brain Stimulation for Movement Disorders – A Novel technique, Accuracy and Clinical Outcome.

    J. Shah, F. Panov (NEW YORK, USA)

    Objective: To study the accuracy of lead placement and clinical outcome of a novel technique using twist drill hole and smaller incision in Magnetic resonance…
  • 2025 International Congress

    Long-term outcomes of subthalamic Deep Brain Stimulation in LRRK2 patients

    C. Lazaro Hernandez, A. Garrido Pla, A. Sanchez Gomez, A. Cadena Fernandez, J. Bejarano Hernandez, F. Valldeoriola Serra (Barcelona, Spain)

    Objective: To compare the basal characteristics and postoperative clinical outcomes of LRRK2 mutation carriers and idiopathic Parkinson’s disease patients treated with subthalamic deep brain stimulation…
  • 2025 International Congress

    Does 10-year STN-DBS impact the natural progression of Parkinsons Disease? A Multicenter Retrospective Controlled Observational Study

    A. Gozzi, S. Convenga, L. Romito, F. Bove, F. Cavallieri, E. Scelzo, R. Cilia, R. Eleopra, V. Fraix, A. Castrioto, AR. Bentivoglio, C. Piano, I. Isaias, A. Priori, M. Sensi, D. Azzolina, P. Pellissier, S. Meoni, E. Moro (Grenoble, France)

    Objective: to evaluate the long-term risk of wheelchair confinement and motor function in Parkinson’s disease (PD) patients undergoing subthalamic deep brain stimulation (STN-DBS), compared to…
  • 2025 International Congress

    Prodromal Clinical Markers of Parkinson disease in patients with Gaucher disease and their parents

    WZ. Hu, Q. Yang, Y. Huang (Guangzhou, China)

    Objective: To determine the presence of prodromal markers of Parkinson’s disease (PD) in Gaucher disease (GD) patients and their parents. Background: GBA gene mutation is…
  • 2025 International Congress

    Effect of Patient Education Interventions on Non-Motor Symptoms and Disease Outcomes in Parkinson’s Disease: A systematic review

    L. van Doeselaer, K. Colman, F. Dijkstra, D. Crosiers (Wilrijk, Belgium)

    Objective: To evaluate whether education interventions on non-motor symptoms (NMS) in Parkinson’s disease (PD) patients contribute to better disease outcomes. Background: Parkinson’s disease is the…
  • 2025 International Congress

    A Survey On The Changes Of Non-Motor Symptoms And Quality Of Life In Patients With Parkinson’s Disease After Bilateral Subthalamic Nucleus Deep Brain Stimulation

    J. Wang, D. Zhu, Y. Gao, L. Wang, D. Li, B. Sun, Y. Wu, X. Qiu (Shanghai, China)

    Objective: This study aims to explore the trajectory of non-motor symptom (NMS) changes in Parkinson's disease (PD) patients after bilateral subthalamic nucleus (STN) deep brain…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
    • VIT-D and Tics Movement Disorder
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley